Risk prediction models for melanoma: a systematic review
- PMID: 24895414
- DOI: 10.1158/1055-9965.EPI-14-0295
Risk prediction models for melanoma: a systematic review
Abstract
Melanoma incidence is increasing rapidly worldwide among white-skinned populations. Earlier diagnosis is the principal factor that can improve prognosis. Defining high-risk populations using risk prediction models may help targeted screening and early detection approaches. In this systematic review, we searched Medline, EMBASE, and the Cochrane Library for primary research studies reporting or validating models to predict risk of developing cutaneous melanoma. A total of 4,141 articles were identified from the literature search and six through citation searching. Twenty-five risk models were included. Between them, the models considered 144 possible risk factors, including 18 measures of number of nevi and 26 of sun/UV exposure. Those most frequently included in final risk models were number of nevi, presence of freckles, history of sunburn, hair color, and skin color. Despite the different factors included and different cutoff values for sensitivity and specificity, almost all models yielded sensitivities and specificities that fit along a summary ROC with area under the ROC (AUROC) of 0.755, suggesting that most models had similar discrimination. Only two models have been validated in separate populations and both also showed good discrimination with AUROC values of 0.79 (0.70-0.86) and 0.70 (0.64-0.77). Further research should focus on validating existing models rather than developing new ones.
©2014 American Association for Cancer Research.
Similar articles
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2. Cochrane Database Syst Rev. 2015. PMID: 26102272 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
Cited by
-
Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.J Korean Med Sci. 2019 Apr 29;34(16):e126. doi: 10.3346/jkms.2019.34.e126. J Korean Med Sci. 2019. PMID: 31020815 Free PMC article.
-
Malignant Melanoma Clinically Masquerading Vascular Tumor: A Diagnostic Dilemma.Indian J Dermatol. 2015 Nov-Dec;60(6):606-8. doi: 10.4103/0019-5154.169137. Indian J Dermatol. 2015. PMID: 26677278 Free PMC article.
-
External validation of models for predicting risk of colorectal cancer using the China Kadoorie Biobank.BMC Med. 2022 Sep 8;20(1):302. doi: 10.1186/s12916-022-02488-w. BMC Med. 2022. PMID: 36071519 Free PMC article.
-
Independent validation of six melanoma risk prediction models.J Invest Dermatol. 2015 May;135(5):1377-1384. doi: 10.1038/jid.2014.533. Epub 2014 Dec 30. J Invest Dermatol. 2015. PMID: 25548858
-
Global-genome Nucleotide Excision Repair Controlled by Ubiquitin/Sumo Modifiers.Front Genet. 2016 Apr 28;7:68. doi: 10.3389/fgene.2016.00068. eCollection 2016. Front Genet. 2016. PMID: 27200078 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical